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Abstract
The novel SARS-CoV-2 outbreak was declared as pandemic by the World Health Organization (WHO) on March 11, 2020.
Understanding the airborne route of SARS-CoV-2 transmission is essential for infection prevention and control. In this study, a
total of 107 indoor air samples (45 SARS-CoV-2, 62 bacteria, and fungi) were collected from different wards of the Hajar
Hospital in Shahrekord, Iran. Simultaneously, bacterial and fungal samples were also collected from the ambient air of hospital
yard. Overall, 6 positive air samples were detected in the infectious 1 and infectious 2 wards, intensive care unit (ICU), computed
tomography (CT) scan, respiratory patients’ clinic, and personal protective equipment (PPE) room. Also, airborne bacteria and
fungi were simultaneously detected in the various wards of the hospital with concentrations ranging from 14 to 106 CFUm−3 and
18 to 141 CFU m−3, respectively. The highest mean concentrations of bacteria and fungi were observed in respiratory patients’
clinics and ICUwards, respectively. Significant correlation (p < 0.05) was found between airborne bacterial concentration and the
presence of SARS-CoV-2, while no significant correlation was found between fungi concentration and the virus presence. This
study provided an additional evidence about the presence of SARS-CoV-2 in the indoor air of a hospital that admitted COVID-19
patients. Moreover, it was revealed that the monitoring of microbial quality of indoor air in such hospitals is very important,
especially during the COVID-19 pandemic, for controlling the nosocomial infections.
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Introduction
Hospitals have a relatively high airborne microbial concentra-
tion including bacteria, fungi, and viruses that may spread
respiratory infections, especially for sensitive individuals
(He et al. 2020; Wu et al. 2020). Respiratory infections are
the leading cause of epidemics, causing about 5 million death
per year in the world (Zumla and Niederman 2020). COVID-
19 was first diagnosed in Wuhan, Hubei Province, China, in
December 2019 (Forrester et al. 2020). This infection (novel
coronavirus, severe acute respiratory syndrome coronavirus 2
named SARS-CoV-2) has spread to many countries around
the world and has become a severe threat globally (Holshue
et al. 2020; Ricco et al. 2020).
On March 11, 2020, World Health Organization (WHO)
declared this respiratory infection outbreak as a pandemic,
indicating a significant global conflict with the disease
(WHO 2020). On February 19, 2020, the first case was report-
ed in Iran (Faridi et al. 2020). Until November 24, 2020, a
total of 880,542 confirmed cases and 45,738 deaths were re-
ported in Iran (https://www.worldometers. info/coronavirus/#
countries).
In order to prevent further spread of COVID-19, it is nec-
essary to identify and control all SARS-CoV-2 transmission
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routes (Forrester et al. 2020). Based on previous studies,
SARS-CoV-2 is transmitted through respiratory droplets and
person to person contact (Wang et al. 2020a). The transmis-
sion of aerosols is possible when people are exposed to high
concentrations of aerosols in indoor environments (Jayaweera
et al. 2020; Razzini et al. 2020). Some droplets are directly
emitted from COVID-19 patients during breathing, talking,
sneezing, or coughing and become airborne (Jayaweera et al.
2020; Wang et al. 2020a). Small droplets exhaled by an in-
fected person (even people without symptoms) can travel a
distance of meters in the air, causing spread of COVID-19
(Repici et al. 2020). However, the maximum exact distance
has not yet been determined (Morawska and Cao 2020). The
potential of airborne transmission of SARS-CoV-2 is still be-
ing studied in the world (Buonanno et al. 2020;Morawska and
Cao 2020). Airborne aerosols containing SARS-CoV-2 can
spread in the environment through various activities related
to health care, such as respiratory tract suctioning, intubation,
bronchoscopy, and cardiopulmonary resuscitation (Cheung
et al. 2020; Soma et al. 2020; Wong et al. 2020). Although
the airborne transmission of SARS-CoV-2 is a pathway of
COVID-19 contagion, more evidences are needed in this field
(Buonanno et al. 2020; Morawska and Cao 2020; Setti et al.
2020). According to the studies, SARS-CoV-2 can survive in
aerosols for hours and retain its infectious properties.
Therefore, the transmission of SARS-CoV-2 through aerosols
is possible (Chia et al. 2020; Tan et al. 2020; Yao et al. 2020).
On the other hand, to our knowledge, no research has been
previously carried out to evaluate the bacterial and fungal
density in the indoor air of different wards of hospital during
the COVID-19 pandemic. Therefore, the main objectives of
this study were the following: (1) detecting the SARS-CoV-2
virus in indoor air, (2) investigating the effect of distance to
the COVID-19 patients bed in the detection of SARS-CoV-2
virus in air samples, and (3) monitoring the concentration and
diversity of bacterial and fungal bioaerosols in Hajar Hospital,
Shahrekord, Iran, which is the highest altitude capital city of
Iran.
Materials and methods
Study area and sampling locations
Hajar Hospital is an educational-therapeutic hospital in
Shahrekord, Iran, with over 373 beds. To date, around 1850
patients with confirmed COVID-19 have been admitted to this
hospital from 20th February 2020. Therefore, the indoor en-
vironment of this hospital may be contaminated with SARS-
CoV-2.
Air samples were collected in 10 days during a 2-week
period from July 25 to August 10, 2020. Bioaerosol sampler
set-up was placed in each ward to collect air samples. The
samples were taken from the infectious ward 1 (suspect and
positive), infectious ward 2 (positive), intensive care unit
(ICU), pediatric ward, radiology, computed tomography
(CT) scan, emergency ward, respiratory patients’ clinic, laun-
dry, toilet of COVID-19 patients, and personal protective
equipment (PPE) rooms of staff. Figure 1 shows the location
of indoor air samples collected from the different wards of the
hospital. All air samples were taken in the presence of
COVID-19 patients. During air sampling, 90% of the patients
were equipped with face mask. However, they removed the
masks during talking with the phone and eating. Moreover,
98% of the patients had one companion in infectious 1 and
infectious 2 wards.
Sampling methods
A total of 45 and 62 air samples were taken from different
wards of the hospital for SARS-CoV-2 detection and airborne
bacterial/fungal monitoring, respectively. Also, during the
study, bacterial and fungal samples were collected from the
hospital yard to compare with indoor air samples. The air
samples for virus detection in each ward were collected using
the standardmidget impinger (SKC. Inc., England) containing
20-mL viral transport medium (VTM) at flow rate of 2 L
min−1 for 4 h (480 L) (Faridi et al. 2020). Simultaneously,
the sampling of airborne bacterial and fungal bioaerosols
was also carried out using a single-stage Andersen sampler
(Model EP_120V, SKC, Taiwan). The flow rate of the pump
was 28.3 L min−1 during 5 min and 2 min for bacterial and
fungal samples, respectively. Tryptic soy agar (TSA) and
Sabouraud dextrose agar (SDA) culture media were used for
bacterial and fungal sampling, respectively (Fabian et al.
2005; Zhong et al. 2016). The indoor air sampler was located
at a height of about 1.5 m from the floor. Based on the proto-
col of the Centers for Disease Control and Prevention (CDC)
(May 13, CDC 2020), prior to each sampling, the impingers
were autoclaved and other accessories were disinfected with
alcohol solution 70%. The environmental parameters such as
temperature, relative humidity, and ventilation rate were re-
corded at the beginning and the end of the sampling process.
Finally, all the collected samples were stored in a cool box (4
°C) and immediately transported to the laboratory.
Quantitative real-time PCR assays
Laboratory confirmation of the SARS-CoV-2 in the indoor air
samples was performed using real-time reverse transcription
polymerase chain reaction (RT-PCR). In this regard, RNA
was extracted using the RNJia Virus Kit (Roje-
Technologies, Yazd, Iran) according to the manufacturer’s
protocol. Briefly, 140 μL of each sample was mixed with
560-μL lysis buffer. After appropriate incubation, binding
buffer was added and the mixture was loaded on the silica
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column. High pure viral RNA was eluted from the column
after washing steps. Real-time PCR was conducted for
SARS-CoV-2 RNA-dependent RNA polymerase (RDRP)
on the FAM Channel and the nucleocapsid protein (NP) on
the HEX Channel using the Novel Coronavirus (2019-nCoV)
Nucleic Acid Diagnostic Kit (Pishtazteb Zaman Diagnostics,
Tehran, Iran). RNase P gene was considered for RNA extrac-
tion quality control on the ROX channel. Each reaction mix-
ture was prepared from 4μL of the PCRmaster mix, 0.5 μL of
RT enzyme, 5 μL of primer and probe mixture, 5 μL of RNA
template, and 5.5 μL of water. The real-time PCR was per-
formed using Rotor-Gene-Q instrument (Qiagen, Germany).
Amplification cycling was optimized on 50 °C for 20 min, 95
°C for 4 min, followed by 45 cycles of 94 °C for 10 s and 55
°C for 40 s. A positive control and a negative control were
considered for all assays. Any tubes with sharp amplification
curves in the logarithmic phase of both target genes (RDRP
and NP) were considered as positive infected samples to
COVID-19. Otherwise, the data was invalid, and the experi-
ment should be repeated. All samples were analyzed in
duplicate.
Identification of bacterial and fungal bioaerosols
To detect bacterial content, the plates of TSA culture media
were incubated for 48–72 h at 35–37 °C. Also, SDA plates
were placed at 20–28 °C (laboratory temperature) for 3–5 days
(Sautour et al. 2009; Hamad and Soliman 2020; Dehghani
et al. 2018). Following the enumeration of the number of
colonies, the concentration of bacterial and fungal bioaerosols
in the air samples was expressed as CFU m−3. The bacterial
genera were identified by Gram staining and biochemical tests
(catalase, oxidase, coagulase, oxidation/fermentation (OF),
and MR/VP). The fungal samples were observed using a fluo-
rescence microscope at 100× to 400× magnification.
Statistical analysis
Descriptive statistics of the variables were presented as mini-
mum, maximum, mean, and standard deviation (± SD). The
normality of data distribution was checked by Kolmogorov-
Smirnov test. The comparisons between groups were per-
formed with analysis of parametric test. One-way ANOVA
Fig. 1 The locations of indoor air samples in the different wards of hospital
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was used to analyze the statistical difference of airborne bac-
terial and fungal concentrations among different wards of the
hospital. An independent sample t test was applied for corre-
lating the airborne bacterial and fungal concentrations with
SARS-CoV-2. p < 0.05 was considered statistically signifi-
cant. Statistical analysis was performed using IBM SPSS sta-
tistics software, version 23.
Results
SARS-CoV-2 detection
Airborne bioaerosol sampling was conducted in different
wards of Hajar Hospital in Shahrekord, Iran. All COVID-19
patients had severe respiratory and gastrointestinal symptoms
at the time of sampling. Specifications of all indoor air sam-
ples for SARS-CoV-2 detection are shown in Table 1. The
study showed that, among all 45 collected indoor air samples,
6 samples were positive for the presence of SARS-CoV-2.
Also, the additional air sampling condition information are
presented in Table S1.
Diversity of airborne bioaerosol concentration
The descriptive statistics of airborne bacterial and fungal
bioaerosols are presented in Table 2. As seen, the highest
mean concentrations of bacteria (88 CFU m−3) and fungi
(77 CFU m−3) were observed at respiratory patients clinic
and ICU, respectively.
One-way ANOVA results showed that there was no signif-
icant variation (p > 0.05) in the view of airborne bacterial and
fungal concentration levels among the different wards of the
hospital.
On the other hand, t test analysis showed that in each ward,
the SARS-CoV-2 samples were positive (n = 6), the mean
bacterial concentration (65 CFU m−3) was higher than the
other wards with negative result for SARS-CoV-2 (n = 25).
Also, significant correlation (p < 0.05) was observed between
the airborne bacterial concentration and the presence of
SARS-CoV-2 in different wards. But it was not applicable to
the fungi concentration.
The results showed that airborne Gram-negative bacilli and
Gram-positive cocci were the most detected bacterial genera
in the air of the hospital wards. However, Gram-negative ba-
cilli were detected at higher frequency (75%) in the air of the
ICU ward. As Fig. 2 shows, the most predominant bacteria
were a genus of Staphylococcus, Bacillus, and Pseudomonas.
Also, the most prevalent fungi genera in all the surveyed
wards were Cladosporium spp. followed by Alternaria spp.,
Penicillium spp., and Yeast ssp. But Aspergillus spp. were
only found in the ICU ward. As well as, the average concen-
tration of airborne bacterial bioaerosols in the hospital yard
(39 ± 5 CFU m−3) was lower than that in the infectious wards,
respiratory patients’ clinic, and emergency ward, but it was
more than the other wards. In addition, the average concentra-
tion of fungal bioaerosols in the hospital yard (115 ± 62 CFU
m−3) was higher than that in all of the indoor air samples.
Moreover, Staphylococcus epidermidis, Acinetobacter,
Pseudomonas , Enterobacter aerogenes , Proteus ,
Staphylococcus aureus , Micrococcus , Neisseria ,
Streptococcus bacteria and the Scopulariopsis, Mycelium,




The COVID-19 outbreak and rapid transmission of extreme
deadly virus SARS-CoV-2 have affected the whole world.
Airborne transmission of SARS-CoV-2 is still controversial,
and the overall evidence for SARS-CoV-2 airborne transmis-
sion has become a global challenge. Hence, in the present
study, indoor air samples were collected from the various
wards of Hajar Hospital, Shahrekord (Iran) to determine the
potential of airborne transmission of SARS-CoV-2.
Of the 45 samples collected in this study, 6 samples
(13.33%) had positive RT-PCR results for SARS-CoV-2.
Five positive air samples were detected 2 m away from the
patients’ beds in infectious 1, infectious 2, ICU, CT scan, and
respiratory patients’ clinic wards. Also, one sample was pos-
itive in the PPE room of the infectious 2 ward. However, no
positive samples were detected in radiology, pediatrics, toilet
of COVID-19 patients, and emergency wards. During the air
sampling in pediatric ward, only one 7-year-old child with
moderate respiratory symptoms was hospitalized. In the radi-
ology ward, after visiting each COVID-19 patient, mechanical
ventilation systems were turned on for 15 min. All fans were
on and all windows were opened during the air sampling of
COVID-19 patients’ toilets.
Patients admitted to the emergency ward had symptoms of
COVID-19 disease and suspected in terms of SARS-CoV-2.
After taking the diagnostic clinical test, the patients with se-
vere respiratory symptoms were transferred to the infectious 2
ward. However, no positive air samples were found in this
ward.
Also, no positive samples were found in the air of the
laundry ward (special for COVID-19 patients). It is notewor-
thy that laundry ward was equipped with a mechanical venti-
lation system as well as natural ventilation.
As opposed to our study, in Faridi et al. (2020) study,
all 10 air samples collected from ICU wards of Imam
Khomeini Hospital complex, Tehran (Iran) were negative
for SARS-CoV-2. Also, all air samples taken from
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infection isolation rooms of a hospital in Singapore were
nega t ive fo r SARS-CoV-2 (Ong e t a l . 2020) .
Additionally, our results are in contrast with the recently
published report by WHO that reported the airborne trans-
mission of SARS-CoV-2 is not the transmission route for
the COVID-19 pandemic (WHO 2020).
Table 1 The SARS-CoV-2 detections in the indoor air of different wards of Hajar hospital








PCR results # of positive
samples
Infectious 1 Patients’ rooms 3 2 12 Yes Natural Positive 1
4 5 Negative 0
PPE’ rooms 2 Not applicable Not applicable Yes Natural Negative 0
Corridor 2 Not applicable Not applicable Yes Natural Negative 0
Toilet 2 Not applicable Not applicable Yes Natural Negative 0
Infectious 2 Patients’ rooms 3 2 14 Yes Natural Positive 1
4 5 Negative 0
PPE’ rooms 2 Not applicable Not applicable Yes Natural Positive 1
Corridor 2 Not applicable Not applicable Yes Natural Negative 0
Toilet 2 Not applicable Not applicable Yes Natural Negative 0
ICU 3 2 15 Yes Mechanical Positive 1
3 5 Negative 0
Pediatric 2 2 1 Yes Natural Negative 0
Radiology 2 2 About 12 per day Yes Mechanical Negative 0
CT scan 2 2 About 60 per day Yes Mechanical Positive 1
Emergency 2 Not applicable About 30 per day Yes Natural Negative 0
Respiratory patients
clinic
3 2 About 110 per day Yes Natural Positive 1
Laundry 2 Not applicable Not applicable Not applicable Mechanical Negative 0
Sum 45 6
a Sneeze or cough during sampling
Table 2 Descriptive statistics of airborne bacteria, fungi, and SARA-CoV-2 in the surveyed wards
Ward Bacteria (CFU m−3) p value Fungi (CFU m−3) p value
Mean ± SD Max Min Mean ± SD Max Min
Infectious 1 44 ± 31 106 14 0.273*a 44 ± 30 88 18 0.055*b
Infectious 2 41 ± 34 99 14 53 ± 25 106 35
ICU 19 ± 8 28 14 77 ± 57 141 35
Pediatric ward 39 ± 15 49 28 35 ± 25 53 18
Radiology 39 ± 5 42 35 44 ± 12 53 35
CT scan 32 ± 5 35 28 53 ± 25 71 35
Emergency ward 60 ± 5 64 57 27 ± 12 35 18
Respiratory patients clinic 88 ± 15 99 78 62 ± 12 71 53
Laundry 25 ± 5 28 21 62 ± 37 88 35
Presence of SARS-CoV-2 6 positive 65 ± 37 99 14 0.02**c 38 ± 13 53 18 0.24**d
25 negative 36 ± 23 106 14 54 ± 30 141 18
*ANOVA, **t test
a The correlation of bacterial concentrations between the surveyed wards
b The correlation of fungal concentrations between the surveyed wards
c The correlation of bacterial concentrations with presence of SARS-CoV-2
d The correlation of fungal concentrations with presence of SARS-CoV-2
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Recently, Kenarkoohi et al. (2020) study detected 2
positive air samples in the ICU ward at Shahid Mustafa
Khomeini Hospital of Ilam, Iran. Their finding indicated
that the airborne transmission of SARS-CoV-2 is possible
and more stringent infection prevention and control (IPC)
approaches should be considered in ICUs. The same re-
port also highlighted the fact that the nosocomial trans-
mission of SARS-CoV-2 aerosols in health-care facilities
is possible (Jayaweera et al. 2020).
Also, Chia et al. (2020) detected SARS-CoV-2 PCR-
positive particles in the air of ventilation equipped infection
isolation rooms in the hospital general ward. However, they
reported that airborne aerosols are not a key route of SARS-
CoV-2 transmission and to confirm the potential airborne
transmission route of the virus, more data on infectiousness
and viability are required.
Santarpia et al. (2020) reported that aerosol particles of
SARS-CoV-2 can produce by respiration, toileting, and fo-
mite contact. Also, air samples were positive for SARS-
CoV-2 at greater than distance of 2 m from patients and relat-
ed hallways (Santarpia et al. 2020).
The hypothesis of the SARS-CoV-2 spreading up to more
than 2 m away has been documented in recently published
studies. If people wear face masks in all their daily activities,
a distance of 2 m can be effective (Setti et al. 2020). Based on
the recent studies and epidemiological observations, the
SARS-CoV-2 virus can be transmitted via air up to 10 m from
the emission sources especially in inadequately ventilated en-
vironments (Setti et al. 2020). Moreover, Guo et al. (2020)
detected the SARS-CoV-2 aerosols at near air outlets
(35.7%), in patients’ rooms (44.4%), and in the doctors’ of-
fices (12.5%). Their findings indicated that SARS-CoV-2
aerosols were distributed in the air and the maximum trans-
mission distance of SARS-CoV-2 aerosol was found to be 4
m.
On the other hand, Judson and Munster (2019) expressed
the ‘airborne transmission’ to describe the disease spread by














































































Fig. 2 a Relative abundance of
the bacterial and b fungal
bioaerosols in the different wards
and yard of the hospital
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be applied for the transmission of COVID-19 (Judson and
Munster 2019). In this regard, Bourouiba (2020) study report-
ed that small droplets are probably transferred to the distance
of 7–8 m during sneezing. In addition, Lee et al. (2019) re-
ported that larger droplets and finer aerosols can travel up to 2
and 6 m, respectively. However, it should be noted that travel
distance is affected by suspension time and size of droplets, air
change rate, and the condition of ward vent openings (Nissen
et al. 2020). But, in our study, no positive sample was found at
a distance of 5 m from the COVID-19 patients’ bed.
Moreover, more extensive distancing measures (distance
among persons up to 10 m) should be performed inside indoor
environments when face masks are not used. In the case of the
common use of face masks, the distance among persons can
be reduced to 2 m (Setti et al. 2020). Because SARS-CoV-2
virus may remain infectious into aerosol droplets at least 3 h
(Van Doremalen et al. 2020), wearing a mask in public places
is strongly recommended.
The inconsistencies in the results of recent studies can be
due to the limited numbers of samples, difference in the air
sampling method, and RT-PCR analysis. The results and con-
ditions of SARS-CoV-2 detection in the air samples in recent
studies are presented in Table 3. As seen, the definite distance
that SARS-CoV-2 can travel from the patients’ beds is
controversial.
In the present study, the variability in the SARS-CoV-2
contamination between hospital wards was interesting. It in-
dicated that an effective management should be considered to
prevent the spread of SARS-CoV-2 from contaminated to
clean wards. However, WHO recommendations about venti-
lation rate in health care facilities, avoidance of air recircula-
tion, and separation between COVID-19 patients and healthy
subjects should be considered.
Overall, we suggest that avoiding busy crowds, social dis-
tancing, behavioral management, and wearing face masks can
decline the spread of the SARS-CoV-2 virus in public build-
ings. The application of these measurements will greatly pre-
vent the transmission of the virus. Finally, airborne transmis-
sion potential of SARS-CoV-2 needs more and more
evidences.
There are some limitations in our study which should be
addressed. First, the positive RT-PCR results did not indicate
a viable virus in the samples. Therefore, in a conservative
manner, we just stated that the SARS-CoV-2 RNA was pres-
ent in the indoor air of the hospital. Second, the difficulty in
the detection of low levels of SARS-CoV-2 in the air samples
that needs to enhance virus culture techniques.
Concentration and types of bioaerosols
In the present study, 13 bacterial species and 9 fungal genera
were detected in the air of the surveyed wards. It was found
that Staphylococcus epidermidis was the most frequently
isolated bacteria from the air of different hospital wards,
followed by Klebsiella and Pseudomonas. Also, our results
revealed that only Pseudomonas spp. and Staphylococcus
epidermidiswere detected in the ICUward. The study showed
that the bacteria found in the indoor air samples were oppor-
tunistic pathogens that are important causes of nosocomial
infections. The main sources of bacteria in the hospital wards
are from the staff, visitors, and patient activity (respiration,
coughing, and sneezing), ward dust, and poor ventilation sys-
tem (Frias-De Leon et al. 2016; Saadoun et al. 2008).
According to the results, the fungal bioaerosol concentra-
tion in the ICU was higher than the other wards. Previous
studies have shown that the most common fungal bioaerosols
in various hospital wards were Penicil l ium spp.,
Cladosporium spp., and Aspergillus (Dehghani et al. 2018;
Kim et al. 2010). Cladosporium spp. is responsible for many
fungal infections in the hospital. Several factors affect indoor
concentration of fungal airborne such as sampling season,
temperature, relative humidity, ventilation system, type of ad-
mitted patients, building materials, and outdoor fungal load
(Abbasi and Samaei 2020). The results of study showed that
the concentration of fungal bioaerosols in outdoor samples
were higher than that in the hospital wards. Moreover, it is
worth to mention that all the fungi species detected in outdoor
samples were also found in the indoor ones, but some bacteria
species like Staphylococcus epidermidis, Acinetobacter,
Pseudomonas , Enterobacter aerogenes , Proteus ,
Staphylococcus aureus, Micrococcus, Neisseria, and
Streptococcus were just detected in the indoor samples.
Likewise, some fungal species like Scopulariopsis,
Mycelium, and Mucor were only found in indoor samples.
Therefore, it seems that some bacterial and fungal species
present in the indoor environment of the hospital were
probably originated from ambient air due to some outdoor
activities. Sautour et al. (2009) and Mirhoseini et al. (2020)
studies have confirmed this result. However, some other spe-
cies were stemmed from the indoor environment.
Overall, in this study, airborne bioaerosol concentra-
tion in the ICU and respiratory patients’ clinic was higher
than the other wards. The high concentration of airborne
bacterial and fungal bioaerosols could be considered as an
important risk factor for COVID-19 patients with severe
acute respiratory syndrome that admitted to these wards.
Due to the fact that the number of people admitted to the
respiratory patients clinics has increased during the
COVID-19 pandemic, they can be affected by microbial
load in this ward.
On the other word, long-term inhalation of high bacterial
concentration may have adverse effects on human health, es-
pecially for sensitive individuals (Wu et al. 2020) like
COVID-19 patients.
In addition, because of the significant association (p < 0.05)
between bacteria levels and the virus presence in our study,
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the presence of high concentrations of bacteria, especially op-
portunistic pathogens, can lead to secondary infections (Smith
and Sweet 2002) and probably increase mortality rate in
COVID-19 patients.
The significant correlation of airborne bacterial levels
and SARS-CoV-2 in various wards of hospital implies
that the bacterial contamination of indoor air can be con-
sidered as a surrogate for the presence of SARS-CoV-2.
In this regard, monitoring the microbial quality of indoor
air in hospitals admitting COVID-19 patients is an impor-
tant and necessary factor for controlling the nosocomial
infections and respiratory diseases and to somewhat
guarantee the absence of SARS-CoV-2 in air. Increasing
the ventilation rate (mechanical or natural systems), peri-
odic monitoring of the microbial quality in the indoor air
of hospitals, controlling the temperature and humidity,
and performing regular disinfection, can reduce the micro-
bial population in the indoor air of health care facilities.
Conclusion
The present study provides the first report on the bacterial and
fungal diversity in indoor air of hospital during COVID-19
Table 3 The results and conditions of SARS-CoV-2 detection in air samples in recent studies



















Iran 14 2 - Impinger DMEM 3 h ICU, Laboratory ward, CT scan,
Radiology, Men and Woman
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ICU and Hospital entrance hall
Ong et al.
(2020)
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Guo et al.
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China 40 14 4 SASS 2300 Wetted
Wall Cyclone
Sampler
- 30 min ICU, general COVID-19 ward
Chia et al.
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China 29 1 1 m of the patient’s head Membrane VTM 1 h Patient rooms, corridor outside the




Korea 9 0 1 m of the patient’s bed SKC BioSampler PBS 20 min Patient rooms
Nissen et al.
(2020)












- 3 h Ward rooms
This study Iran 45 6 2, 5 Impinger VTM 4 h Infectious 1 and 2 wards, ICU,
Pediatric ward, CT scan,
Emergency ward, Laundry,
Respiratory patients clinic
DMEM Dulbecco’s Modified Eagle’s Medium, PTFE polytetrafluoroethylene, PBS phosphate-buffered saline
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pandemic. In this regard, we detected 6 positive indoor air
samples, which were collected from nine different wards of
the hospital. Five positive samples were found at a distance of
2 m from the COVID-19 patient’s bed. Moreover, none of the
air samples were positive in the distance of 5 m from the
COVID-19 patients’ bed. It seems that the safe physical dis-
tance from COVID-19 patients are more than 2 m. Our find-
ings showed that the fungal concentrations were higher than
the bacterial concentration in indoor air of the hospital. The
most isolated bacterial bioaerosols were Staphylococcus spp.,
Bacillus spp., and Pseudomonas spp. in all samples. In addi-
tion, the main fungal species detected in the air of COVID-19
patients’ rooms were Cladosporium spp., Alternaria spp., and
Yeast spp. Also, the significant correlation (p < 0.05) was
found between airborne bacterial concentration and SARS-
CoV-2. Overall, this study provided an additional evidence
on the presence of SARS-CoV-2 in indoor air of hospitals
admitting COVID-19 patient, especially near the patients’
bed. Moreover, it was revealed that the control of microbial
quality of indoor air in such hospitals is crucial. The results of
this study imply that the contact with bioaerosols generated
through COVID-19 patients, health care workers, and visitors’
exhalation in the hospital wards may pose serious health threat
especially for susceptible individuals. Hence, it is essential to
supply fresh and sterilized air in various hospital wards.
Abbreviations WHO, World Health Organization; ICU, Intensive care
unit; CT, Computed tomography; PPE, Personal protective equipment;
VTM, Viral transport medium; TSA, Tryptic soy agar; SDA, Sabouraud
dextrose agar; CDC, Centers for Disease Control and Prevention; RT-
PCR, Real-time reverse transcription polymerase chain reaction; RDRP,
RNA-dependent RNA polymerase; NP, Nucleocapsid protein; OF,
Oxidation/fermentation
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